A real-world evidence study evaluating a treatment for nappy rash

Area of Science:

• Dermatology
• Pediatrics
• Pharmacology

Background:

• Infantile nappy rash (NR) is a common condition requiring effective treatment.
• Assessing real-world treatment efficacy provides valuable clinical insights.

Purpose of the Study:

• To evaluate the real-world effectiveness of Sudocrem Antiseptic Healing Cream (SAHC) for infantile nappy rash (NR).
• To determine the speed of healing and impact on daily life when using SAHC for NR.

Main Methods:

• Retrospective, open-label study utilizing real-world evidence.
• Online questionnaire with Likert scales administered to participants who previously used SAHC.
• Data collected from 1818 respondents who treated NR within the prior six months.

Main Results:

• Over 50% experienced NR improvement on the same day of SAHC treatment initiation.
• 94.5% reported NR improvement within three days; 72.5% achieved complete healing.
• By day five, 94.7% of cases showed complete healing of NR.
• 71% reported minimal disruption to daily life, though 29% noted a noticeable impact.

Conclusions:

• SAHC demonstrates rapid efficacy in treating infantile nappy rash (NR) based on real-world data.
• The cream effectively reduces signs and symptoms of inflammation, leading to quick healing.
• SAHC offers a viable treatment option for infantile nappy rash, minimizing patient discomfort and disruption.